Tag: FDA

Read-Across Is No Longer Optional: Why It Is Becoming Central to Modern Chemical Safety Assessment

Jon Redmond /September 8, 2026

Toxicology | Regulatory Insight Read-across has evolved from a data-gap-filling exercise into the framework that integrates NAMs, exposure science, and toxicokinetics to support modern risk assessment decisions. For years, read-across,…

FDA Adds Bemotrizinol to Sunscreen Monograph

Jon Redmond /September 1, 2026

Product Safety | Regulatory Insight For the first time since the late 1990s, the U.S. Food and Drug Administration (FDA) has added a new active ingredient to the over-the-counter (OTC)…